- Home
- KYMR vs WAL Comparison
KYMR vs WAL Comparison
Compare KYMR & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KYMR | WAL |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | United States |
| Employees | N/A | 3524 |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.6B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KYMR | WAL |
|---|---|---|
| Price | $119.06 | $82.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 26 | 14 |
| Target Price | ★ $107.72 | $91.69 |
| AVG Volume (30 Days) | ★ 1.2M | 867.0K |
| Earning Date | 04-30-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 2.11% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,211,000.00 | N/A |
| Revenue This Year | $10.61 | $20.49 |
| Revenue Next Year | $8.17 | $8.08 |
| P/E Ratio | ★ N/A | $10.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $36.88 | $65.82 |
| 52 Week High | $130.05 | $97.23 |
Technical Indicators
Market Signals| Indicator | KYMR | WAL |
|---|---|---|
| Relative Strength Index (RSI) | 76.01 | 53.53 |
| Support Level | $72.91 | $77.31 |
| Resistance Level | $130.05 | $85.02 |
| Average True Range (ATR) | 7.67 | 2.15 |
| MACD | 2.01 | 0.04 |
| Stochastic Oscillator | 76.15 | 64.15 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.